UBE2C and glioblastoma: Using a scoring system combining intensity and frequency of UBE2C staining (Figure 2F), we have observed that most BM samples (55%) have high levels of UBE2C (Score III and IV), in contrast with glioblastomas in which 70% of the samples have low expression of this protein (Figure 2G).